Bret Koplow explained the agency's position in an Oct. 26 letter to Glas Inc.
After the bill was signed, FDA was given 90 days to publish it's lists
Jessica Zeller brings more than 20 years of legal experience to the role
Concurrent with DEA's Notice of Intent
The FDA Memo is only two pages
The guidance addresses the type of scientific evidence FDA expects applicants to submit
FDA was originally given 90 days to publish
There is a bipartisan legislation in the works to delay the ban until 2028
The bans will reappear sooner than later
The FDA research is intended to help fill a void in dosage knowledge